| Literature DB >> 28916976 |
Daniel J Lobatto1, Friso de Vries2, Amir H Zamanipoor Najafabadi2, Alberto M Pereira3, Wilco C Peul2, Thea P M Vliet Vlieland4, Nienke R Biermasz3, Wouter R van Furth2.
Abstract
BACKGROUND: The ability to preoperatively predict postoperative complication risks is valuable for individual counseling and (post)operative planning, e.g. to select low-risk patients eligible for short stay surgery or those with higher risks requiring special attention. These risks however, are not well established in pituitary surgery.Entities:
Keywords: Bleeding; CSF leak; Diabetes insipidus; Endoscopic transsphenoidal surgery; Pituitary; Risk factors
Mesh:
Year: 2018 PMID: 28916976 PMCID: PMC5767215 DOI: 10.1007/s11102-017-0839-1
Source DB: PubMed Journal: Pituitary ISSN: 1386-341X Impact factor: 4.107
Summary of findings (risk of bias)
| Authors | Study participation | Study attrition | Prognostic factor measurement | Outcome measurement | Study confounding | Statistical analysis and reporting | Overall risk of bias |
|---|---|---|---|---|---|---|---|
| Ajlan 2016 | Moderate | Moderate | Moderate | Moderate | High | High |
|
| Bokhari 2013 | Moderate | Moderate | Moderate | Moderate | High | High |
|
| Boling 2016 | Low | Moderate | Moderate | Moderate | Moderate | Low |
|
| Cavallo 2014 | Moderate | Moderate | Moderate | Moderate | High | High |
|
| Cerina 2016 | Moderate | Moderate | Low | Low | Low | Low |
|
| Chabot 2015 | Low | Moderate | Low | Moderate | High | Moderate |
|
| Chi 2013 | Moderate | Moderate | Low | Moderate | Moderate | Moderate |
|
| Chohan 2016 | Moderate | Low | Moderate | Moderate | Moderate | Moderate |
|
| Dallapiaza 2014 | Moderate | High | Moderate | Moderate | High | Moderate |
|
| Dlouhy 2012 | Moderate | Moderate | Low | Moderate | Low | Low |
|
| Gondim 2011 | Moderate | Low | Moderate | Low | High | Low |
|
| Gondim 2015 | Moderate | Low | Moderate | Moderate | High | Moderate |
|
| Hofstetter 2012 | Moderate | Low | Low | Low | High | Moderate |
|
| Jakimovski 2014 | Moderate | Moderate | Moderate | Moderate | High | Moderate |
|
| Jang 2016 | Moderate | Low | Moderate | Low | Moderate | Moderate |
|
| Karnezis 2016 | Low | Moderate | Moderate | Moderate | Moderate | Low |
|
| Leach 2010 | Moderate | Low | Moderate | Moderate | High | Moderate |
|
| Qureshi 2016 | Moderate | Moderate | Moderate | Moderate | Moderate | Moderate |
|
| Senior 2008 | Low | Moderate | Moderate | Low | High | Moderate |
|
| Sigounas 2008 | Moderate | Moderate | Moderate | Low | Low | Low |
|
| Thawani 2017 | Moderate | Moderate | Moderate | Moderate | Moderate | Moderate |
|
| Zhan 2015 | Moderate | Moderate | Moderate | Moderate | High | Moderate |
|
| Zhang 2014 | Moderate | Moderate | Moderate | Moderate | Moderate | Low |
|
Fig. 1Flow chart of study assessment
Study types and demographics
| Authors, institution | Study design | Study interval | Number of patients (n) | Adenomas (%) | Females (%) | Mean age (years) | Complications |
|---|---|---|---|---|---|---|---|
| Ajlan et al. [ | Retro | 2007–2012 | 176 | 100 | 52 | 50 (median) | Postoperative CSF leak 4.5%, bleeding 1.7%, epistaxis 1.1%, visual deterioration 1.1%, permanent DI 10.2% |
| Bokhari et al. [ | Retro | 1998–2010 | 79 | 100 | 56 | 56.7 | Postoperative CSF leak 2.5%, meningitis 0, bleeding 1.3%, visual deterioration 1.3%, transient DI 10%, permanent DI 2.5%, death 1.3% |
| Boling et al. [ | Retro | 2002–2014 | 982 | 100 | 56 | 52 | Postoperative CSF leak 5.5%, meningitis 2.7%, bleeding 3.7%, death 0.5% |
| Cavallo et al. [ | Retro | 1997–2012 | 83 | 0 | 53 | 50.4 | Postoperative CSF leak 16.9%, meningitis 1.2%, bleeding 4.8%, visual deterioration 2.4%, overall DI 36.1%, SIADH 3.6%, death 2.4% |
| Cerina et al. [ | Pro | 2012–2013 | 70 | 100 | 60 | 44.4 | Adrenal insufficiency 51.4% |
| Chabot et al. [ | Retro | 2009–2014 | 39 | 100 | 36 | 56.3 | Postoperative CSF leak 10.3%, meningitis 2.6%, visual deterioration 0, overall DI 7.7% |
| Chi et al. [ | Retro | 2011–2012 | 80 | 100 | 44 | 50.9 | Postoperative CSF leak 5%, meningitis 1.3%, bleeding 0, visual deterioration 0, transient DI 11.3%, permanent DI 3.8%, death 0 |
| Chohan et al.[ | Retro | 2003–2014 | 62 | 100 | 34 | 54.2 (median) | Postoperative CSF leak 1.6%, bleeding 1.6%, visual deterioration 9.7%, permanent DI 17.7%, death 0 |
| Dallapiazza et al. [ | Retro | 2010–2013 | 56 | 100 | 52 | 56.2 | Postoperative CSF leak 7.1%, meningitis 0, epistaxis 10.7%, visual deterioration 3.6%, adrenal insufficiency 14.3%, transient DI 17.9%, permanent DI 0, SIADH 8.9% |
| Dlouhy et al. [ | Retro | 2005–2010 | 92 | 92 | 52 | 53.0 | Postoperative CSF leak 13.5% |
| Gondim et al.[ | Retro | 1998–2009 | 301 | 100 | 55 | 42.4 | Postoperative CSF leak 2.6%, meningitis 0.6%, bleeding 1.7%, epistaxis 2.0%, visual deterioration 0.3%, permanent DI 1.3%, death 1.0% |
| Gondim et al. [ | Retro | 2000–2012 | 374 | 100 | 59 | 51 | Postoperative CSF leak 3.7%, bleeding 1.6%, permanent DI 2.7%, death 1.1% |
| Hofstetter et al. [ | Pro | 2004–2010 | 71 | 100 | 46 | 49.9 | Postoperative CSF leak 1.4%, bleeding 1.4%, visual deterioration 1.4%, permanent DI 4.2%, death 1.4% |
| Jakimovski et al. [ | Pro | 2003–2011 | 203 | 100 | 49 | – | Postoperative CSF leak 3.0%, meningitis 1.0%, bleeding 1.5%, visual deterioration 1.0%, adrenal insufficiency 2.0%, overall DI 3.9% |
| Jang et al. [ | Retro | 1998–2014 | 331 | 100 | 56 | 47.4 | Postoperative CSF leak 1.8%, meningitis 0.6%, bleeding 0.6%, epistaxis 1.2%, transient DI 4.2%, permanent DI 0.9%, SIADH 2.7%, death 0.3% |
| Karnezis et al. [ | Retro | 2002–2014 | 1161 | 95 | 54 | 51 | Postoperative CSF leak 5.9% |
| Leach et al. [ | Retro | 2005–2007 | 125 | 87 | 44 | 51 | Postoperative CSF leak 3.2%, bleeding 1.6%, epistaxis 1.6%, visual deterioration 1.6%, overall DI 4.8%, death 0 |
| Qureshi et al. [ | Retro | 2006–2012 | 78 | 100 | 45 | 52.6 | Postoperative CSF leak 1.3%, transient DI 11.5%, permanent DI 2.6% |
| Senior et al. [ | Retro | 2000–2007 | 176 | 84 | 54 | 46 | Postoperative CSF leak 11.4%, meningitis 1.1%, bleeding 0.5%, epistaxis 3.1%, visual deterioration 0, overall DI 20.2%, death 0.5% |
| Sigounas et al. [ | Retro | 2000–2005 | 110 | 85 | 52 | – | Postoperative CSF leak 10.0%, transient DI 13.6%, permanent DI 2.7% |
| Thawani et al. [ | Retro | 2009–2014 | 203 | 100 | 49 | 55.7 | Postoperative CSF leak 10.3%, meningitis 1.0%, bleeding 0.5%, visual deterioration 1.5%, transient DI 3.9%, permanent DI 4.4%, SIADH 5.9%, death 1.0% |
| Zhan et al. [ | Retro | 2008–2014 | 313 | 100 | 40 | 60.1 | Postoperative CSF leak 3.8%, meningitis 1.6%, bleeding 0.6%, visual deterioration 1.9%, transient DI 15.4%, permanent DI 3.8%, death 0 |
| Zhang et al. [ | Retro | 2007–2011 | 326 | 100 | 46 | 33.3 | Meningitis 9.8% |
(–) not assessed
(*) South Carolina, USA; Adelaide, Australia; NY, USA (2); Toronto, Canada; Atlanta, USA; Cleveland, USA
(**) South Carolina, USA; Adelaide, Australia; NY, USA (2); Toronto, Canada; Atlanta, USA; Cleveland, USA, Alabama, USA
(1) New York Presbyterian (2) Mt. Sinai Medical Center (3) Hofstra-North Shore Long Island Jewish Hospital
(†) Illinois, USA; NY, USA (3)
Described risk factor per complication
| Complications in general | Postoperative CSF leak | Intracranial infection | Bleeding | Adrenal insufficiency | Transient DI | Permanent DI | Overall DI | |
|---|---|---|---|---|---|---|---|---|
| Demographics | ||||||||
| Age | + | =25,33,27, − | =27 | =27 | =16 | =27 | =27 | =27,33 |
| Gender (female*) | =31 | =24,25,33, + | =16 | =25,33 | ||||
| BMI | =25, + | |||||||
| Diabetes mellitus | + | |||||||
| Race | =34 | =26 | ||||||
| Peptic ulcer disease | + | |||||||
| Various comorbidities | =34 | |||||||
| Volumetric parameters | ||||||||
| Tumor size | =22, + | =18,25,33, + | + | =26,29,29,29
| =25,26,33 | |||
| Tumor volume | + | =18,24,36 | =29 | |||||
| Intraventricular extension | + | + | + | + | ||||
| Knosp | =22, + | =36 | =29 | |||||
| Supra-/parasellar extension | + | + | ||||||
| Extension into the ACF | + | + | ||||||
| Cavernous sinus invasion | =28 | =28,33 | ||||||
| Pathology | ||||||||
| Tumor type | =31 | =18, + | =16 | |||||
| Non-functioning adenoma | =26 | |||||||
| Acromegaly | =26 | |||||||
| Cushing’s disease | =24 | =26 | ||||||
| Prolactinoma | =26 | |||||||
| RCC | + | + | + | |||||
| Craniopharyngioma | + | =26 | ||||||
| Surgical factors | ||||||||
| Previous radiation | + | =20,33, + | + | |||||
| Previous surgery | =24,33,34 | =26,26 | =25,26,26 | |||||
| Learning curve | =19,35 | =19,23,32, + | =32 | =32 | =19,23 | |||
| Endocrine parameters | ||||||||
| Preoperative prolactin/TSH/testosterone/cortisol | =16 | |||||||
| Preoperative T4/IGF-1/FSH/LH | + | |||||||
| Urinary-free cortisol (nmol/24 h) | + | |||||||
Significant associations are given in bold
*Prognostic factor has a higher change of outcome
+ Positive effect; indicating a significant higher risk
− Negative effect; indicating a significant lower risk
= Neutral; relation studied, however no significant increased/decreased risk found
Summary of preoperative risk factors for postoperative complications
| Complications in general | CSF leak | Intracranial infections | Bleedings | Adrenal insufficiency | DI | |
|---|---|---|---|---|---|---|
| Amendable | ||||||
| Learning curve | = | Decreased after >50 cases | = | |||
| Non-amendable | ||||||
| Age | Increased ≥50–70 years | Increased <65 years | = | = | = | = |
| Gender | = | Increased in females | = | = | ||
| BMI | Higher BMI or >30 kg/m2 | |||||
| Diabetes mellitus | Increased risk | |||||
| Race | = | = | ||||
| Peptic ulcer disease | Increased risk | |||||
| Large or giant tumors | Increased in larger tumors | Increased in larger tumors | = | = | Increased in larger tumors | Increased >1 cm |
| Invasive tumors | Increased by increased extension | Increased by increased extension | Increased by increased extension | Increased by increased extension | = | = |
| Tumor type | = | Increased in RCC/craniopharyngioma | = | Increased in RCC | ||
| Previous radiation | Increased risk | Increased risk | Increased risk | |||
| Previous surgery | = | = | ||||
| Preoperative hypopituitarism/T4/IGF-1/FSH/LH/UFC | Increased risk | |||||
Risk ratios can be found in supplementary table 2 (online supplement)
= Neutral; relation studied, however no significant increased/decreased risk found